ADMA - CIK 0001368514
The table below shows ADMA BIOLOGICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $138.15M | $61.38M | $90.28M | $71.63M | $86.71M | $88.24M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $135.86M | $137.67M | $109.73M | $99.41M | $50.14M | $30.11M |
| Inventory | $222.10M | $196.67M | $191.46M | $172.19M | $171.80M | $179.81M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $511.17M |
| $402.65M |
| $399.56M |
| $351.81M |
| $318.19M |
| $303.69M |
| Property, plant & equipment | $65.01M | $69.51M | $57.50M | $57.71M | $53.69M | $54.33M |
| Goodwill | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M |
| Total assets | $665.18M | $568.69M | $558.38M | $510.57M | $390.62M | $376.40M |
| Accounts payable | $20.52M | $24.02M | $29.77M | $20.61M | $16.02M | $14.18M |
| Total current liabilities | $73.54M | $56.49M | $74.94M | $53.50M | $44.89M | $44.18M |
| Long-term debt | $193.58M | $70.08M | - | - | - | - |
| Total liabilities | $274.86M | $137.50M | $160.06M | $137.15M | $158.73M | $188.13M |
| Retained earnings | -$116.33M | -$211.03M | -$247.46M | -$281.68M | -$420.48M | -$456.39M |
| Total equity | $390.32M | $431.19M | $398.32M | $373.42M | $231.89M | $188.27M |